Related Experiment Videos
Penicillamine--a new therapy of retinitis pigmentosa
Indian Journal of Ophthalmology
|December 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ocular motility in alternating squints: an electro-oculographic study.
The British journal of ophthalmology·1982
Effect of penicillamine on the sensori-neural deafness of retinitis pigmentosa.
The Journal of laryngology and otology·1977
Copper metabolism in retinitis pigmentosa.
The British journal of ophthalmology·1976
Vitamin A nutritional status of rural community of Khol block in Haryana, North India. A collaborative study.
The American journal of clinical nutrition·1975
Visual impairment and blindness among the residents of blind schools in Jammu province: A cross-sectional survey.
Indian journal of ophthalmology·2026
Emerging role of stem cells and tissue engineering in oculoplastic surgery.
Indian journal of ophthalmology·2026
Efficiency and safety of argon laser in trichiasis: A systematic review and meta-analysis.
Indian journal of ophthalmology·2026
IgG4-related orbital disease - An update.
Indian journal of ophthalmology·2026
Utility of ultrasound biomicroscopy in detecting invasive ocular surface squamous neoplasia.
Indian journal of ophthalmology·2026
Patient-Derived 3D Cell Models as New Approach Methodologies: Applications, Advances, and Challenges for Increased-Throughput Assays.
SLAS discovery : advancing life sciences R & D·2026
Top-Down Proteomics in the Assessment of Kidney Donor Quality: a proof-of-concept for increased organ utilization.
Molecular & cellular proteomics : MCP·2026
Innovative liposomal amphotericin B formulation for oral treatment of visceral leishmaniasis.
International journal of pharmaceutics·2026
Immune memory engineering in mRNA therapeutics.
Journal of controlled release : official journal of the Controlled Release Society·2026
HLA-DPB1 TCE mismatch vector differentially affects HCT outcomes in 10/10 and ≤9/10 HLA matched patients in the UK.
Transplantation and cellular therapy·2026